{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T20:21:56Z","timestamp":1771878116674,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Department of Biotechnology, Government of India","award":["BT\/PR3150\/MED\/30\/640\/2011"],"award-info":[{"award-number":["BT\/PR3150\/MED\/30\/640\/2011"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jsbmb.2018.01.007","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T14:20:58Z","timestamp":1515594058000},"page":"15-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Effect of vitamin D supplementation on serum sclerostin levels in chronic kidney disease"],"prefix":"10.1016","volume":"180","author":[{"given":"Ashok Kumar","family":"Yadav","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debasish","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishan Lal","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivekanand","family":"Jha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2018.01.007_bib0005","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0010","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0015","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1093\/ndt\/gfr591","article-title":"The connections between vascular calcification and bone health","volume":"26","author":"Cannata-Andia","year":"2011","journal-title":"Nephrol. Dial Transpl."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0020","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0025","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2215\/CJN.10091110","article-title":"Bone alkaline phosphatase and mortality in dialysis patients","volume":"6","author":"Drechsler","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0030","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1681\/ASN.2008010014","article-title":"Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients","volume":"19","author":"Regidor","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0035","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","article-title":"Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population","volume":"26","author":"Floege","year":"2011","journal-title":"Nephrol. Dial Transpl."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0040","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1759720X13510479","article-title":"Role of sclerostin in bone and cartilage and its potential as a therapeutic target in bone diseases","volume":"6","author":"Lewiecki","year":"2014","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0050","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2215\/CJN.07670712","article-title":"The relation between renal function and serum sclerostin in adult patients with CKD","volume":"8","author":"Pelletier","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0055","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1073\/pnas.1221255110","article-title":"Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium","volume":"110","author":"Ryan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0060","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/EJE-13-0862","article-title":"Effect of supplemental vitamin D and calcium on serum sclerostin levels","volume":"170","author":"Dawson-Hughes","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0065","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2005.03.018","article-title":"SOST is a target gene for PTH in bone","volume":"37","author":"Keller","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0070","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1210\/en.2005-0239","article-title":"Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis","volume":"146","author":"Bellido","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0075","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1210\/jc.2009-2283","article-title":"Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women","volume":"95","author":"Mirza","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0080","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1002\/jbmr.479","article-title":"Determinants of serum sclerostin in healthy pre- and postmenopausal women","volume":"26","author":"Ardawi","year":"2011","journal-title":"J. Bone Min. Res."},{"issue":"9","key":"10.1016\/j.jsbmb.2018.01.007_bib0085","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1055\/s-0035-1559790","article-title":"Effect of vitamin D treatment on serum sclerostin level","volume":"125","author":"Acibucu","year":"2017","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0090","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00296-015-3294-1","article-title":"Serum sclerostin is decreased following vitamin D treatment in young vitamin D-deficient female adults","volume":"35","author":"Cidem","year":"2015","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0095","doi-asserted-by":"crossref","first-page":"682763","DOI":"10.1155\/2014\/682763","article-title":"Changes in dickkopf-1 (DKK1) and sclerostin following a loading dose of vitamin D 2 (300,000 IU)","volume":"2014","author":"Sankaralingam","year":"2014","journal-title":"J. Osteoporos."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0100","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.numecd.2016.11.005","article-title":"Active vitamin D treatment in CKD patients raises serum sclerostin and this effect is modified by circulating pentosidine levels","volume":"27","author":"Torino","year":"2017","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0105","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1681\/ASN.2017010003","article-title":"A randomized trial of vitamin D supplementation on vascular function in CKD","volume":"28","author":"Kumar","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0110","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wnt\/beta-catenin signaling is an early event in the progression of renal osteodystrophy","volume":"27","author":"Sabbagh","year":"2012","journal-title":"J. Bone Min. Res."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0115","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and Dickkopf-1 in renal osteodystrophy","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0120","doi-asserted-by":"crossref","first-page":"E1854","DOI":"10.1210\/jc.2014-2042","article-title":"Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients","volume":"99","author":"Kanbay","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0125","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1056\/NEJM199709043371003","article-title":"Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older","volume":"337","author":"Dawson-Hughes","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0130","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1210\/jc.2010-0720","article-title":"Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women","volume":"95","author":"Drake","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0135","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jbmr.217","article-title":"Relation of age, gender, and bone mass to circulating sclerostin levels in women and men","volume":"26","author":"Modder","year":"2011","journal-title":"J. Bone Min. Res."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0140","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1210\/jc.2013-2113","article-title":"Association of circulating sclerostin with bone mineral mass, microstructure, and turnover biochemical markers in healthy elderly men and women","volume":"98","author":"Durosier","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2018.01.007_bib0145","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI28551","article-title":"Regulation of bone mass by Wnt signaling","volume":"116","author":"Krishnan","year":"2006","journal-title":"J. Clin. Invest."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076018300086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076018300086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:57:34Z","timestamp":1760745454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076018300086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":29,"alternative-id":["S0960076018300086"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2018.01.007","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of vitamin D supplementation on serum sclerostin levels in chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2018.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}